Beta
Fluconazole
medication Under reviewA triazole antifungal medication used to treat and prevent various fungal infections, including candidiasis and cryptococcal meningitis.
Research summary
Fluconazole has demonstrated clinical efficacy in treating various fungal infections in human subjects. In a prospective clinical trial of 17 evaluable patients with deep-seated fungal infections, clinical cure or improvement was achieved in 82% of cases, with particularly strong effectiveness against candidal infections. The medication has been shown to be effective in preventing or suppressing candidiasis in both HIV-negative and HIV-positive populations. Research indicates that fluconazole has a favorable safety profile with no serious adverse effects documented in clinical trials of healthy subjects.
Reported Benefits
No reports yet
Be the first to report this effect and help the community.
Add Fluconazole to your stack to report effects
A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections.
Not specified
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Not specified
No side effects tracked yet
No side effects have been reported by studies or users for this habit yet.
Related health conditions
Research showing how this habit affects specific health conditions. Always consult healthcare professionals.
May Help With
General digestive problems including bloating, irregular bowel movements, and discomfort
A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections.
Not specified
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Not specified
Research (2 studies)
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Not specified
A prospective study of the efficacy of fluconazole (UK-49,858) against deep-seated fungal infections.
Not specified
Community updates
No updates yet for this supplement.
Be the first to share your experience!